Q&A Session 3 – ASG Webinar – 11/12

Amyloidosis Support Groups webinar on ATTR amyloidosis from July 23, 2022. Led by ASG President Muriel Finkel, featured speakers Jignesh K. Patel, MD, PhD, Cedars-Sinai California Heart Center, Beverly Hills, CA; Chafic Karam, MD, Neurologist, Associate Professor of Neurology, University of Pennsylvania, Philadelphia, PA; Michael Maitland, MD, PhD, Sr. Director, Clinical Development, Intellia Therapeutics; Colleen Moffitt, PharmD, MS, US ATTR Medical Director, Alnylam Pharmaceuticals; Gustavo Buchele, MD, PhD, Executive Director, Clinical Development, Ionis Pharmaceuticals; Craig Spolsky, Advocacy & Professional Relations Director, Pfizer, Inc.; Chris Olson, Senior Director, Vyndamax Access & Patient Solutions, Pfizer, Inc., and Jonathan Wall, PhD, Professor, University of Tennessee Graduate School of Medicine, Knoxville, TN, presents the third Q&A session.